Investigating the global genomic diversity of Escherichia coli using a multi-genome DNA microarray platform with novel gene prediction strategies
2011

Exploring the Genomic Diversity of E. coli

Sample size: 207 publication 10 minutes Evidence: high

Author Information

Author(s): Jackson Scott A, Patel Isha R, Barnaba Tammy, LeClerc Joseph E, Cebula Thomas A

Primary Institution: U.S. Food and Drug Administration

Hypothesis

Can a multi-genome DNA microarray accurately assess the genomic diversity of Escherichia coli?

Conclusion

The study reveals significant genomic diversity among E. coli strains, highlighting the effectiveness of a novel microarray-based analysis in molecular epidemiology.

Supporting Evidence

  • The study analyzed 207 isolates to assess genomic diversity.
  • Results showed that individual strains of O157:H7 differed by an average of 197 gene targets.
  • The microarray approach allowed for accurate gene presence/absence determination.
  • Findings contribute to understanding microbial forensics and molecular epidemiology.

Takeaway

Scientists looked at many different E. coli germs to see how different they are from each other, and they found a lot of differences that help understand how these germs can make people sick.

Methodology

The study used the Affymetrix GeneChip® E. coli Genome 2.0 Array to analyze the gene content of 207 E. coli and Shigella isolates.

Potential Biases

Potential biases may arise from the selection of strains and the inherent limitations of the microarray design.

Limitations

The study may not capture all genetic variations due to the limitations of the microarray technology.

Participant Demographics

The study included 207 diverse isolates of E. coli and Shigella from various sources.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2164-12-349

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication